FYERS
Hindustan Bio Sciences7.16
-0.37 (-4.91%)

Hindustan Bio Sciences Share Price

7.16-0.37 (-4.91%)
-10.72% past 1 Year

Corporate filings & documents

Announcements

In terms of Regulation 30 and 47 of SEBI (LODR) 2015 we are hereby attaching the Newspaper publication of 34th Notice of Annual General Meeting Book Closure and E-voting.
2 weeks ago
In terms of Regulation 30 and 47 of SEBI (LODR) 2015 we are hereby attaching the Newspaper publication of 34th Notice of Annual General Meeting Book Closure and E-voting.
2 weeks ago
With Reference to the subject cited please find the 34th Annual Report along with the intimation for the financial year 2025-26
2 weeks ago
With Reference to the subject cited please find the 34th Annual Report along with the intimation for the financial year 2025-26
2 weeks ago
Submission of 34th Annual Report including the notice of Annual General Meeting for the financial year 2025-26 under regulation 34 of SEBI (LODR) Regulation 2015
2 weeks ago
Submission of 34th Annual Report including the notice of Annual General Meeting for the financial year 2025-26 under regulation 34 of SEBI (LODR) Regulation 2015
2 weeks ago
Outcome of the Board Meeting held on 31-08-2026
2 weeks ago
Outcome of the Board Meeting held on 31-08-2026
2 weeks ago
Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2026 inter alia to consider and approve Draft scheme of Reorganization/Rearrangement of Share Capital of the company
3 weeks ago
Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2026 inter alia to consider and approve Draft scheme of Reorganization/Rearrangement of Share Capital of the company
3 weeks ago
Newspaper Publication of un-audited financial results for the quarter ended 30th June 2026
1 month ago
Newspaper Publication of un-audited financial results for the quarter ended 30th June 2026
1 month ago
Approval of Un-audited Financial Results of the company for the first quarter ended 30 june 2026 along with Limited Review Report issued by statutory auditor
1 month ago
Approval of Un-audited Financial Results of the company for the first quarter ended 30 june 2026 along with Limited Review Report issued by statutory auditor
1 month ago
Outcome of the Board Meeting held on Friday July 31 2026 as Required under Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015
1 month ago
Outcome of the Board Meeting held on Friday July 31 2026 as Required under Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015
1 month ago
Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve With reference to the subject cited this is to inform the Exchange that meeting of the Board of Directors of M/s. Hindustan Bio Sciences Limited will be held on Friday the 31st day of July 2026. at the registered office of the company situated at Plot No: 31 Sagar Co-Operative Housing Society Road No: 2 Banjara Hills Hyderabad - 500 034 to consider the following:1. Un-audited financial results of the company for the quarter ended 30.06.20262. Any other matter with the permission of Chair.
2 months ago
Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve With reference to the subject cited this is to inform the Exchange that meeting of the Board of Directors of M/s. Hindustan Bio Sciences Limited will be held on Friday the 31st day of July 2026. at the registered office of the company situated at Plot No: 31 Sagar Co-Operative Housing Society Road No: 2 Banjara Hills Hyderabad - 500 034 to consider the following:1. Un-audited financial results of the company for the quarter ended 30.06.20262. Any other matter with the permission of Chair.
2 months ago
We are hereby submitting the Compliance Certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with 74(5) of SEBI(D&P) Regulations 2018 for the first quarter ended 30th June 2026
2 months ago
We are hereby submitting the Compliance Certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with 74(5) of SEBI(D&P) Regulations 2018 for the first quarter ended 30th June 2026
2 months ago
The trading window for dealing in the securities of the company will remain closed from 01st July 2026 till 48 hours after announcement of Standalone Un-Audited Financial results for the quarter ending on June 30 2026
2 months ago
The trading window for dealing in the securities of the company will remain closed from 01st July 2026 till 48 hours after announcement of Standalone Un-Audited Financial results for the quarter ending on June 30 2026
2 months ago
Newspaper publication as per regulation 47 of SEBI (LODR) 2015.
3 months ago
Appointment of Internal Auditor for the year 2026-27
3 months ago
Appointment of Internal Auditor for the year 2026-27
3 months ago
Audited Financial Results for the Fourth Quarter and Financial year ended 31st March 2026
3 months ago
Audited Financial Results for the Fourth Quarter and Financial year ended 31st March 2026
3 months ago
Financial Results for the Fourth Quarter and Financial Year ended 31st March 2026
3 months ago
Financial Results for the Fourth Quarter and Financial Year ended 31st March 2026
3 months ago
Annual Secretarial Compliance Report for the year ended 31 March 2026
4 months ago
Annual Secretarial Compliance Report for the year ended 31 March 2026
4 months ago
Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Hindustan Bio Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Intimation of Board Meeting under regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure requirements) regulations 2015
4 months ago
Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Hindustan Bio Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Intimation of Board Meeting under regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure requirements) regulations 2015
4 months ago
We are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with the Regulation 74(5) of SEBI(Depositories and Participants) Regulation 2018 for the Fourth quarter and year ended on 31st March 2026
5 months ago
We are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with the Regulation 74(5) of SEBI(Depositories and Participants) Regulation 2018 for the Fourth quarter and year ended on 31st March 2026
5 months ago
The Trading window for the dealing in securities of the Company will remain closed from April 01 2026 till 48 hours after the announcement of Standalone Audited Financial results for the year ending on March 31 2026
5 months ago
The Trading window for the dealing in securities of the Company will remain closed from April 01 2026 till 48 hours after the announcement of Standalone Audited Financial results for the year ending on March 31 2026
5 months ago
We are hereby submitting the Newspaper Advertisement in Hitech Edition (English Language) and Prajapalana (Telugu Language) regarding Unaudited Standalone financial results for the Third Quarter ended on December 31 2025
7 months ago
Un-audited results for quarter ended 31-12-2025
7 months ago
Outcome of Board Meeting
7 months ago
The Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bosco Armando Menezes & Emily Bosco Menezes
7 months ago
Intimation under SAST regulation 29(2)
8 months ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bosco Armando Menezes & Emily Bosco Menezes
8 months ago
Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 inter alia to consider and approve Intimation of Board Meeting under regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure requirements) regulations 2015
8 months ago
Special window for re-lodgment of transfer requests of physical shares pursuant to SEBI circular dated July 2 2025
8 months ago
Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the period ended 31st December 2025
8 months ago
Closure of Trading Window
8 months ago
Special Window for re-lodgment of transfer requests of physical shares pursuant to SEBI circular dated July 2 2025
9 months ago
Newspaper Publication of Un-audited financial results for the half year and quarter ended 30th September 2025
10 months ago
Outcome of board meeting held on 31-10-2025
10 months ago

Annual reports

FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Hindustan Bio Sciences Ltd Share Price Today

The Hindustan Bio Sciences Ltd share price today is ₹7.75. During the trading session, the Hindustan Bio Sciences Ltd share price opened at ₹7.45 and recorded an intraday high of ₹7.80 and a low of ₹7.10. Last closing price was ₹7.45. Over the past 52 weeks, the Hindustan Bio Sciences Ltd share price has ranged between ₹5.00 and ₹9.92. The current Hindustan Bio Sciences Ltd stock price reflects real-time market activity based on executed trades on the exchange.